Azvudine for the Treatment of COVID-19 in Pre-Existing Cardiovascular Diseases: A Single-Center, Real-World Experience
This study indicated that Azvudine therapy is associated with better outcomes in COVID-19 patients with pre-existing cardiovascular diseases.PMID:38544344 | DOI:10.1002/advs.202306050
Source: Adv Data - Category: Epidemiology Authors: Liu Wu Zhong-Han He Ling Huang Xin Guo Xu-Yong Li Hong-Da Zhang Man-Hua Chen Source Type: research
More News: Cardiology | Cardiovascular | China Health | COVID-19 | Epidemiology | Heart | Study | Urology & Nephrology